why choose us

First received: August 24, 2022

Clinical Trial: Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hematopoietic Stem Cell Transplant (HSCT)

Study Type: INTERVENTIONAL


Official Title: Pilot Trial of Pravastatin as a Novel Prophylactic Medicine to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

Brief Summary: Chemotherapy and radiation used in patients undergoing bone marrow transplant (BMT) disrupts the endothelial lining (a thin layer of cells inside the blood vessels) which is found all throughout the body including the kidney, heart, lungs, and intestines.Disruption of this endothelial lining can lead to complications such as graft-vs-host disease (GVHD), thrombotic microangiopathy (TMA) and veno-occlusive disease (VOD).The purpose of this research study is to help investigators see if pravastatin is safe and well…

Read more